ClinConnect ClinConnect Logo
Search / Trial NCT00273728

BaSES Trial: Basel Starch Evaluation in Sepsis

Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Jan 6, 2006

Trial Information

Current as of April 25, 2025

Completed

Keywords

Hydroxyethyl Starch Shock, Septic Infusion, Intravenous Mortality

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Patients with suspected or proven infection and 2 of the following 6 criteria:
  • Body temperature \<36 or \>38.3° celsius
  • Heart rate \> 90 beats/min
  • Tachypnea \> 20/min or a arterial pCO2 below 4.25 kPa
  • White blood cell count higher than 12.000 or below 4.000 or more than 10% immature forms
  • Systolic blood pressure \<90 mmHg or mean arterial pressure \< 65 mmHg
  • Altered mental state or oliguria
  • Exclusion Criteria:
  • Pregnancy
  • Age below 18
  • Allergy against Hydroxyethyl starch
  • Chronic renal insufficiency

Trial Officials

Martin Siegemund, MD

Principal Investigator

Anaesthesia and Intensive Care, State Hospital, CH-5404 Baden, Switzerland

About University Hospital, Basel, Switzerland

The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.

Locations

Basel, , Switzerland

Basel, , Switzerland

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials